A&G Pharmaceutical

Theranostics company completes series A financing

Published in Health Business Week, September 30th, 2005

A&G Pharmaceutical, Inc., a theranostics company focused on the development of new monoclonal antibody-based therapeutic and diagnostic products, announced that it has raised $2 million in series A financing.

Proceeds from the financing will be used to conduct clinical testing of the company's GP88 Biopsy Staining Kit for breast cancer, under development to help physicians determine prognosis and aid in determining the risk of breast cancer recurrence.

New England Partners served as lead investor for the financing. Other participating investors include the Maryland Venture Fund (the venture arm of the Maryland Department of Business and Economic...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2005-09-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry